ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma.
Winkfield KM, Advani RH, Ballas LK, Dabaja BS, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mansur DB, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Younes A, Constine LS. ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma. Oncology 2016, 30: 1099-103, 1106-8. PMID: 27987203, PMCID: PMC7440297.Peer-Reviewed Original ResearchMeSH KeywordsCombined Modality TherapyHematopoietic Stem Cell TransplantationHodgkin DiseaseHumansPractice Guidelines as TopicRecurrenceTransplantation, AutologousConceptsRecurrent Hodgkin lymphomaHodgkin's lymphomaAppropriateness CriteriaAutologous stem cell transplantationMedical literatureAppropriateness of imagingInnovative targeted therapiesCombined-modality therapyLow-dose therapyACR Appropriateness CriteriaEarly-stage diseaseStem cell transplantationMultidisciplinary expert panelRadiology Appropriateness CriteriaEvidence-based guidelinesSpecific clinical conditionsSpecific clinical scenariosCurrent medical literatureRecent medical literaturePeer-reviewed journalsRecurrent diseaseSalvage optionCell transplantationTargeted therapyClinical conditions